BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
125 results:

  • 1. Fertility counselling and fertility preservation among early onset female cancer patients-A Finnish register-based study.
    Melin J; Holopainen E; Savolainen-Peltonen H
    Cancer Med; 2024 Feb; 13(3):e7034. PubMed ID: 38400669
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survey on the implementation status and reproductive outcomes of oocyte and ovarian tissue cryopreservation in Japan: Historical comparison with nationwide surveys.
    Takae S; Harada M; Nakamura K; Furuyama S; Ono M; Osuga Y; Suzuki N
    J Obstet Gynaecol Res; 2024 Apr; 50(4):709-718. PubMed ID: 38263596
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?
    Benvenuti C; Laot L; Grinda T; Lambertini M; Pistilli B; Grynberg M
    ESMO Open; 2024 Feb; 9(2):102228. PubMed ID: 38232611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients.
    Barral Y; Borrás A; Carrillo P; Agustí I; Peralta S; Casals G; Fàbregues F; Guimerà M; Corral JM; Calafell JM; Redondo M; Glickman A; Rovira M; Adamo B; Ricart E; Trullàs DM
    Clin Transl Oncol; 2024 May; 26(5):1129-1138. PubMed ID: 37872422
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of Fertility Preservation for Female cancer Patients in a Single Tertiary Center.
    Kim JH; Alzahrani HS; Lee SR; Kim SH; Chae HD
    Yonsei Med J; 2023 Aug; 64(8):497-504. PubMed ID: 37488701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
    Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
    J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Contrast enhanced mammography in breast cancer surveillance.
    Elder K; Matheson J; Nickson C; Box G; Ellis J; Mou A; Shadbolt C; Park A; Tay J; Rose A; Mann GB
    Breast Cancer Res Treat; 2023 Jun; 199(2):221-230. PubMed ID: 36966271
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
    Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Optical Redox Imaging Is Responsive to TGFβ Receptor Signalling in Triple-Negative breast cancer Cells.
    Xu HN; Jacob A; Li LZ
    Adv Exp Med Biol; 2022; 1395():269-274. PubMed ID: 36527648
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Current Status and Issues of the Japan Oncofertility Registry.
    Shigematsu K; Shimizu C; Furui T; Kataoka S; Kawai K; Kishida T; Kuwahara A; Maeda N; Makino A; Mizunuma N; Morishige KI; Nakajima TE; Ota K; Ono M; Shiga N; Tada Y; Takae S; Tamura N; Watanabe C; Yumura Y; Suzuki N; Takai Y
    J Adolesc Young Adult Oncol; 2023 Aug; 12(4):584-591. PubMed ID: 36516123
    [No Abstract]    [Full Text] [Related]  

  • 12. Nano-gold micelles loaded Dox and Elacridar for reversing drug resistance of breast cancer.
    Wen LJ; Wang YS; Zhang J
    IET Nanobiotechnol; 2023 Apr; 17(2):49-60. PubMed ID: 36341719
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced breast cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
    Di Cosimo S; Pérez-García JM; Bellet M; Dalenc F; Gil Gil MJ; Ruiz Borrego M; Gavilá J; Sampayo-Cordero M; Aguirre E; Schmid P; Marmé F; Gligorov J; Schneeweiss A; Albanell J; Zamora P; Wheatley D; Martínez-De Dueñas E; Carañana V; Amillano K; Mina L; Malfettone A; Cortés J; Llombart-Cussac A
    Oncologist; 2023 Jan; 28(1):23-32. PubMed ID: 36239405
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of breast cancer Diagnosis.
    Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
    JAMA Oncol; 2022 Oct; 8(10):1438-1446. PubMed ID: 36006625
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study.
    Goldrat O; De Cooman M; Mailliez A; Delbaere A; D'Orazio E; Demeestere I; Decanter C
    Eur J Cancer; 2022 Oct; 174():134-141. PubMed ID: 35998549
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical outcome of embryo cryopreservation in Japanese breast cancer patients: pregnancy rates after transfer of thawed embryos.
    Okutsu-Horage Y; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
    J Assist Reprod Genet; 2022 Aug; 39(8):1769-1777. PubMed ID: 35980490
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation.
    Wang Y; Tesch ME; Lim C; Xu YH; Lee S; Perdizet K; Yokom D; Warner E; Roberts J; Lohrisch CA
    Breast Cancer Res Treat; 2022 Sep; 195(2):201-208. PubMed ID: 35908122
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibition of Mitochondrial Biosynthesis Using a "Right-Side-Out" Membrane-Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple-Negative breast cancer.
    Peng J; Hu X; Fan S; Zhou J; Ren S; Sun R; Chen Y; Shen X; Chen Y
    Adv Healthc Mater; 2022 Sep; 11(18):e2200742. PubMed ID: 35818932
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fertility Preservation in Young Women with breast cancer: Impact on treatment and Outcomes.
    Crown A; Muhsen S; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
    Ann Surg Oncol; 2022 Sep; 29(9):5786-5796. PubMed ID: 35672625
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study.
    Duraes M; Rathat G; Bringer-Deutsch S; Ranisavljevic N; Brouillet S; Defez-Fougeron C; Duflos C
    Breast; 2022 Aug; 64():121-126. PubMed ID: 35661841
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.